Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.
2.

Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.

Clarke R, Halsey J, Lewington S, Lonn E, Armitage J, Manson JE, Bønaa KH, Spence JD, Nygård O, Jamison R, Gaziano JM, Guarino P, Bennett D, Mir F, Peto R, Collins R; B-Vitamin Treatment Trialists' Collaboration..

Arch Intern Med. 2010 Oct 11;170(18):1622-31. doi: 10.1001/archinternmed.2010.348. Review.

PMID:
20937919
3.

Homocysteine lowering and cardiovascular disease risk: lost in translation.

Marcus J, Sarnak MJ, Menon V.

Can J Cardiol. 2007 Jul;23(9):707-10. Review.

4.

Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.

B-Vitamin Treatment Trialists' Collaboration..

Am Heart J. 2006 Feb;151(2):282-7. Review.

PMID:
16442889
5.
6.

Homocysteine-lowering B vitamins do not lower mortality or cardiovascular events.

Lundberg GD.

Medscape J Med. 2008;10(12):273. Epub 2008 Dec 4. No abstract available.

7.

Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials.

Ebbing M, Bønaa KH, Arnesen E, Ueland PM, Nordrehaug JE, Rasmussen K, Njølstad I, Nilsen DW, Refsum H, Tverdal A, Vollset SE, Schirmer H, Bleie Ø, Steigen T, Midttun Ø, Fredriksen A, Pedersen ER, Nygård O.

J Intern Med. 2010 Oct;268(4):367-82. doi: 10.1111/j.1365-2796.2010.02259.x.

8.

Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.

Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M.

Z Kardiol. 2004 Jun;93(6):439-53. Review.

PMID:
15252738
9.

Homocysteine, B vitamins, and risk of cardiovascular disease.

Robinson K.

Heart. 2000 Feb;83(2):127-30. No abstract available.

10.

Homocysteine: is it a clinically important cardiovascular risk factor?

Lentz SR, Haynes WG.

Cleve Clin J Med. 2004 Sep;71(9):729-34. Review.

PMID:
15478704
11.

Folate supplementation: too much of a good thing?

Ulrich CM, Potter JD.

Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):189-93. No abstract available.

12.

[Effects of folic acid on cerebrovascular and cancer risks].

Martin-Du Pan RC, Mercan D.

Rev Med Suisse. 2012 Feb 15;8(328):375-9. French.

PMID:
22397069
13.

Homocysteine, folic acid, B vitamins and cardiovascular risk.

Blacher J, Safar ME.

J Nutr Health Aging. 2001;5(3):196-9. Review.

PMID:
11458292
14.

Homocysteine-lowering trials for prevention of heart disease and stroke.

Clarke R.

Semin Vasc Med. 2005 May;5(2):215-22. Review.

PMID:
16047274
16.

Homocysteine-lowering vitamins and cardiovascular mortality: are they really effective?

Celik T, Iyisoy A, Yuksel UC, Isik E.

Int J Cardiol. 2008 Aug 29;128(3):432-3. Epub 2007 Aug 8.

PMID:
17689750
17.

Effect of homocysteine interventions on the risk of cardiocerebrovascular events: a meta-analysis of randomised controlled trials.

Mei W, Rong Y, Jinming L, Yongjun L, Hui Z.

Int J Clin Pract. 2010 Jan;64(2):208-15. doi: 10.1111/j.1742-1241.2009.02207.x. Epub 2009 Nov 13. Review.

PMID:
19912385
18.

[Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?].

Méndez-González J, Rodríguez-Millán E, Julve J, Blanco-Vaca F.

Rev Neurol. 2010 Feb 16-28;50(4):235-44. Review. Spanish.

19.

[Homocysteine lowering with folic acid and B vitamins in vascular disease].

Liakishev AA.

Kardiologiia. 2006;46(5):70. Russian. No abstract available.

PMID:
16858361
20.

Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials.

Yang HT, Lee M, Hong KS, Ovbiagele B, Saver JL.

Eur J Intern Med. 2012 Dec;23(8):745-54. doi: 10.1016/j.ejim.2012.07.004. Epub 2012 Aug 11.

PMID:
22884409

Supplemental Content

Support Center